Floatz logo

Calcium folinate pentahydrate

Gallbladder Cancer

Lisata Therapeutics, Inc.Small moleculePhase 2Active
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Gallbladder Cancer cohort.

Asset / SponsorPhaseRating
Eloxatin
Tianjin Medical University Cancer Institute and Hospital
Phase 3BBB
FLUOROURACILUM
Lisata Therapeutics, Inc.
Phase 2BBB
Capecitabine
Merck Sharp & Dohme LLC
Phase 3BB
Carboplatin
Merck Sharp & Dohme LLC
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Lisata Therapeutics, Inc.
Phase 2BB

View all 33 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →